| Previous Close | 0.3600 |
| Open | 0.0000 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 0.3600 - 0.3600 |
| 52 Week Range | 0.2500 - 0.5450 |
| Volume | 60 |
| Avg. Volume | 12,316 |
| Market Cap | 3.874M |
| Beta (3Y Monthly) | 2.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.56 |
| Earnings Date | Mar 1, 2019 - Mar 11, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Over 200 prescribers have written at least one prescription for PRESTALIA and over 600 patients are taking the medication PRESTALIA was launched in Q3 2018, powered by the Company's proprietary DyrctAxess ...
Innovative Technology enables the pharmaceutical industry to transition to an orchestrated commercial model